National Cancer Institute
Do bacteria in cigarettes cause infections?
Submitted by Anonymous on Fri, 2010-01-29 23:15A publication in
Environmental Health Perspectives this month challenges a long-held assumption about tobacco and infections.
People assumed that the reason smokers get a lot of respiratory infections was because the smoke was suppressing their immune systems.
- Read more
- 1367 reads
Biomarkers still pretty limited in ovarian cancer, says study
Submitted by Anonymous on Thu, 2010-01-14 16:27As usual, Paul Cacciatore at H*O*P*E blog comes through with an excellent review of the new paper, published 12/09 in JNCI, the Journal of the National Cancer Institute.
http://healthinfoispower.wordpress.com/2010/01/07/elevated-proteins-may-...
Disclaimer: JNCI is not affiliated in any way with the National Cancer Institute. Crazy! I know this because I called NCI and asked them all about this and...well that's another topic for another post.
- 1153 reads
Dr. Emanuel is busy
Submitted by Anonymous on Fri, 2009-07-17 10:16So I had the bright idea to call Dr. Ezekiel Emanuel. Part of the power trio of Emanuel brothers this seems to be a guy who can get things done in Washington. He has met with Barack Obama to advise him on health care reform written books on the subject etc. I thought I could appeal to him about this JNCI issue. Basically I think the journal of our National Cancer Institute should be free for all American taxpayers to access. We paid for that research and writing and we should get to read it for free. It would be like NOAA making you pay to get the weather data.
- Read more
- 916 reads
Follicular lymphoma vaccine passes phase III milestone for first time
Submitted by Anonymous on Sun, 2009-06-21 22:34- American Society
- author
- California
- Cancer
- Cancer immunotherapy
- Cancer treatments
- chemotherapy
- chief
- director
- Florida
- Follicular lymphoma
- Hematology
- http://www.medscape.com/viewarticle/703926
- Immunology
- Immunotherapy
- Medicine
- Monoclonal antibodies
- National Cancer Institute
- Oncology
- Orlando
- Pennsylvania
- Person Career
- Philadelphia
- Quotation
- Rituximab
- Ron Levy
- Stanford University
- Stanford University in California
- Stephen Schuster
- Technology
- Technology
- the University of Pennsylvania
- treatment of follicular lymphoma
- U.S. Food and Drug Administration
- University of Pennsylvania School
- Vaccine trial
(reproduced from Medscape.com original link: http://www.medscape.com/viewarticle/703926) June 4 2009 (Orlando Florida) — It has been nearly 10 years in coming but at last there is a positive result with a vaccine approach to follicular lymphoma. Two other phase 3 clinical trials have failed but the one that succeeded was reported during a plenary session here at the American Society of Clinical Oncology (ASCO) 45th Annual Meeting.
- Read more
- 1743 reads
Thyroid cancer: a review
Submitted by Anonymous on Tue, 2009-01-20 17:59- Advocate
- Anaplastic thyroid cancer
- author
- Cancer Treatment
- chemotherapy
- energy
- Follicular thyroid cancer
- Goitre
- Graves' disease
- http://www.cancer.gov/cancertopics/types/thyroid
- http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_thyroid_can...
- Hyperthyroidism
- imaging
- Medicine
- Medullary thyroid cancer
- MRI
- National Cancer Institute
- Oncology
- Otolaryngology
- PET
- physician
- radiation
- RAI
- Social Issues
- Social Issues
- surgeon
- surgeon for best results
- Thyroid disease
- Thyroid neoplasm
- Thyroidectomy
- treatment of thyroid cancer
- treatment of thyroid lymphoma
- ultrasound
- United States
Where is the thyroid gland and what is it’s function? The thyroid gland is shaped like a butterfly and sits just below the voice box and in front of the trachea (wind-pipe). It resides under thin muscle layers in the midline central neck just above the sternum and moves with swallowing as it is attached to the trachea. The thyroid gland is a central organ in the body that secretes thyroid hormones and as such regulates our body’s metabolism energy level and various other functions.
- Read more
- 2982 reads
Gleevec gets post-op prevention indication for GIST
Submitted by Anonymous on Thu, 2008-12-25 11:07- American College of Surgeons Oncology Group
- Anatomical pathology
- Cancer
- Chronic myelogenous leukemia
- Disaster
- Disaster
- Duke Clinical Research Institute
- European Union
- FDAPhase
- Gastrointestinal cancer
- Gastrointestinal stromal tumor
- Gleevec
- Imatinib
- Japan
- Medicine
- National Cancer Institute
- Novartis
- Novartis
- Oncology
- Philadelphia
- Philadelphia chromosome
- President and CEO
- Sarcoma
- Surgeons Oncology Group
- the American College
- treatment of this life-threatening cancer
- Tyrosine kinase inhibitors
- U.S. Food and Drug Administration
- Z9001
Gastrointestinal stromal tumor (GIST) is a critical cancer of the gastrointestinal tract. It is also known as soft tissue sarcomas. The prevalence of GIST is likely to be 4 500 - 6 000 new cases per year in the US. Surgery is the normal treatment of local GIST. GIST tumors more often recurs in as many as one of two patients after its initial removal. Repeated GISTs are frequently more persistent than primary tumors with relapses related with lower survival rates. Gleevec is the lone treatment recognized to delay the recurrence of this aggressive cancer.
- Read more
- 1962 reads
Vitamin D does not appear to prevent breast cancer
Submitted by Anonymous on Mon, 2008-12-08 11:39- Breast cancer
- breast cancer prevention
- California
- cancer prevention
- Cedric Garland
- Dietary supplements
- Folic acid
- Health
- Hypovitaminosis D
- Larry Norton
- Medicine
- Memorial Sloan
- National Cancer Institute
- Nutrition
- Orthomolecular medicine
- Other
- Risk factors of breast cancer
- San Diego
- University of California
- University of California San Diego
- Vitamin
- Vitamin D
- Vitamin D
- Vitamins
Researchers have long reported that at least half of American adults are suffering from the deficiency of Vitamin D and speculation has indicated that this deficiency can lead to illnesses from osteoporosis to cancer of the colon and breast. Recently new research has asked whether Vitamin D can avert breast cancer. Earlier studies carried out between the years 1986 and 2000 have highlighted that Vitamin D could protect against cancer.
- Read more
- 1235 reads
Selenium strikes out against prostate cancer
Submitted by Anonymous on Fri, 2008-10-31 09:54- Antioxidants
- Biology
- Cancer
- cancer prevention
- Carotenoids
- Chemistry
- Cleveland
- Cleveland clinic
- coordinator
- Eric Klein
- Finasteride
- Finasteride
- food
- Kidney Institute
- Major
- Medicine
- National Cancer Institute
- Other
- Prostate cancer
- Puerto Rico
- Selenium
- United States
- Urology
- vice chairman
- Vitamin A
- Vitamin E
- Vitamins
Prior research had suggested that Selenium and vitamin E either taken alone or in combination could potentially lower a man’s risk for prostate cancer. Now a more recent randomized clinical trial found just the opposite: not only do these supplements not prevent prostate cancer; they may actually put people’s health at risk. Vitamin E and selenium are antioxidants that exist in relatively small amounts in food.
- Read more
- 1082 reads
More aggressive surgery improves outcomes for recurrent breast cancer
Submitted by Anonymous on Tue, 2008-10-21 22:54- Breast cancer
- Breast surgery
- California
- Cancer
- Co-author
- Lumpectomy
- Lung cancer
- Mammary ductal carcinoma
- Mastectomy
- Medicine
- National Cancer Institute
- Person Career
- Philip Wrenn
- Quotation
- Sacramento
- Social Issues
- Social Issues
- Steven L. Chen
- Steven Martinez
- the American Journal
- therapy for breast cancer
- United States
- University of California
- University of California Davis Cancer Center
by Philip Wrenn A new report has found that a mastectomy is advisable when breast cancer recurs following a lumpectomy. This is due to the fact that survival rates are increased as opposed to cases where another lumpectomy is performed. "We were surprised to find that so many women in our study -- almost a quarter of them -- had received another lumpectomy rather than a mastectomy " noted Dr. Steven L. Chen of the University of California Davis Cancer Center in Sacramento.
- Read more
- 1012 reads
DCIS Return No Greater in Younger Patients Than In Older Ones
Submitted by Anonymous on Fri, 2008-09-26 07:59- American Society
- Ann Partridge
- Aruna Turaka
- Boston
- Breast cancer
- Cancer
- Dana
- Farber Cancer Institute
- Fox Chase Cancer Center
- http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=44394
- Mammary ductal carcinoma
- Medicine
- Medline News National Cancer Institute
- National Cancer Institute
- Oncology
- Other
- Philadelphia
- Quotation
- radiation
- researcher
- Women's Hospital
It was presumed that those women who were forty and younger having been diagnosed were more likely to see a recurrence however that isn't the case says Dr Aruna Turaka from the department of radiation oncology at Fox Chase Cancer Center in Philadelphia. Her new study presented Wednesday at the American Society for Therapeutic Radiology and Oncology annual meeting in Boston found that the presumption was incorrect. From the U.S.
- Read more
- 1465 reads